|
García-Vázquez E, Fernández-Rufete A, Hernández-Torres A, Canteras M, Ruiz J, Gómez J. When is coagulase-negative Staphylococcus bacteraemia clinically significant? Scand J Infect Dis. 2013 Sep;45(9):664-71. doi: 10.3109/00365548.2013.797599. PubMed PMID: 23808723.
AÑO: 2013; IF: 1.64
|
23808723
|
García-Vázquez E, Albendín H, Hernández-Torres A, Canteras M, Yagüe G, Ruiz J, Gómez J. [Study of a cohort of patients with Enterococcus spp. Bacteraemia. Risk factors associated to high-level resistance to aminoglycosides]. Rev Esp Quimioter. 2013 Sep;26(3):203-13. Spanish. PubMed PMID: 24080886.
AÑO: 2013; IF: 0.905
|
|
Gómez J, García-Vázquez E, Hernández-Torres A. [Betalactams in clinical practice]. Rev Esp Quimioter. 2015 Feb;28(1):1-9. Review. Spanish. PubMed PMID: 25690139.
AÑO: 2015; IF: 1.014
|
|
Gómez J, García-Vázquez E, Bonillo C, Hernández A, Bermejo M, Canteras M. [Self-assessment of patterns of antibiotic use in a university hospital]. Enferm Infecc Microbiol Clin. 2014 Oct;32(8):507-10. doi: 10.1016/j.eimc.2014.03.009. Spanish. PubMed PMID: 24889543.
AÑO: 2014; IF: 2.172
|
|
Fernández-Rufete A, García-Vázquez E, Hernández-Torres A, Canteras M, Ruiz J, Gómez J. [Coagulase-negative Staphylococcus bacteraemia: prognosis factors and influence of antibiotic treatment]. Rev Esp Quimioter. 2012 Sep;25(3):199-205. Spanish. PubMed PMID: 22987266.
AÑO: 2012; IF: 0.836
|